These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6340489)

  • 1. Intrinsic sympathomimetic activity of pindolol. Evidence for interaction with pretreatment sympathetic tone.
    Plotnick GD; Fisher ML; Hamilton JH; Hamilton BP
    Am J Med; 1983 Apr; 74(4):625-9. PubMed ID: 6340489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pindolol--a new beta-adrenergic blocking agent with intrinsic sympathomimetic activity in the management of mild and moderate hypertension.
    Schirger A; Sheps SG; Spiekerman RE; Harman TR; Kleven MK
    Mayo Clin Proc; 1983 May; 58(5):315-8. PubMed ID: 6843182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical significance of intrinsic sympathomimetic activity of the beta blocker carteolol. II: Comparative studies of carteolol and pindolol in patients with bradycardia].
    Lohmöller G; Middeke M; Mrowka C; Pötzl C; Renner W; Zoller W
    Med Klin (Munich); 1989 Feb; 84(2):81-5. PubMed ID: 2651861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacology of beta-adrenoceptor blocking drugs possessing partial agonist activity, with special reference to pindolol.
    Aellig WH
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S16-20. PubMed ID: 6188915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsic sympathomimetic activity (ISA) of pindolol in patients with sinus node dysfunction.
    Viersma JW; van den Berg MP; van Gilst WH; Lie KI
    Eur Heart J; 1986 Jan; 7(1):42-6. PubMed ID: 3956521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of intrinsic sympathomimetic activity on regional left ventricular function; use of regional ejection fraction to demonstrate a beneficial action by pindolol over propranolol on hypokinetic segments.
    Johnston DL; Manyari DE; Kostuk WJ
    Can J Cardiol; 1985; 1(3):174-9. PubMed ID: 2996726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacology of pindolol.
    Aellig WH
    Am Heart J; 1982 Aug; 104(2 Pt 2):346-56. PubMed ID: 6125094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrinsic sympathomimetic activity counteracts beta-blocker inhibition of renin activation.
    Ruddy MC; Bialy GB; Kostis JB
    Angiology; 1989 Jan; 40(1):45-50. PubMed ID: 2562912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of intrinsic sympathomimetic activity on respiratory function during chronic beta blockade: comparison of propranolol and pindolol.
    Northcote RJ; Ballantyne D
    Br Med J (Clin Res Ed); 1986 Jul; 293(6539):97-9. PubMed ID: 3089433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of beta blockade and intrinsic sympathomimetic activity on hemodynamics, inotropy and respiration at rest and during exercise.
    Sundberg S; Gordin A
    Am J Cardiol; 1986 Jun; 57(15):1394-9. PubMed ID: 2872795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of pindolol and propranolol on exercise performance in young men with systemic hypertension.
    Martin NB; Broeder CE; Thomas EL; Wambsgans KC; Scruggs KD; Jesek JK; Hofman Z; Wilmore JH
    Am J Cardiol; 1989 Aug; 64(5):343-7. PubMed ID: 2756879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in depressed cardiac function in hypertensive patients during pindolol treatment.
    Plotnick GD; Fisher ML; Wohl B; Hamilton JH; Hamilton BP
    Am J Med; 1984 Jan; 76(1):25-30. PubMed ID: 6691357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
    Floras JS; Jones JV; Hassan MO; Sleight P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pindolol and propranolol in patients with angina pectoris and normal or near-normal ventricular function. Lack of influence of intrinsic sympathomimetic activity on global and segmental left ventricular function assessed by radionuclide ventriculography.
    Manyari DE; Kostuk WJ; Carruthers SG; Johnston DJ; Purves P
    Am J Cardiol; 1983 Feb; 51(3):427-33. PubMed ID: 6401908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of beta blockade, with and without intrinsic sympathomimetic activity, in preserving compromised left ventricular function in patients with ischemic heart disease.
    Gebhardt VA; Wisenberg G
    Am Heart J; 1985 May; 109(5 Pt 1):1013-20. PubMed ID: 2859772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of beta blockade and intrinsic sympathomimetic activity on exercise performance.
    Ades PA; Brammell HL; Greenberg JH; Horwitz LD
    Am J Cardiol; 1984 Dec; 54(10):1337-41. PubMed ID: 6507309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrinsic sympathomimetic activity of labetalol.
    Tadepalli AS; Novak PJ
    J Cardiovasc Pharmacol; 1986; 8(1):44-50. PubMed ID: 2419691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute hemodynamic effects of pindolol and propranolol in patients with dilated cardiomyopathy: relevance of intrinsic sympathomimetic activity.
    Shanes JG; Wolfkiel C; Ghali J; Dierenfeldt BJ; Kondos GT; Bauman JL
    Am Heart J; 1988 Nov; 116(5 Pt 1):1268-75. PubMed ID: 3189143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta blockers with intrinsic sympathomimetic activity.
    White WB
    Am Fam Physician; 1985 Jan; 31(1):115-8. PubMed ID: 2857059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pindolol and systolic time intervals in patients with hypertension.
    Hammond JJ; Kirkendall WM; Jacks-Nagle VL; Plotnick GD; Fisher ML; Hamilton JH; Robinson M; Carliner NH; Janoski AH; Hamilton BP
    Am Heart J; 1982 Aug; 104(2 Pt 2):456-64. PubMed ID: 7102532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.